nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

01.07.2013 | SSIEM Symposium 2012

The neuropsychiatry of inborn errors of metabolism

verfasst von: Mark Walterfang, Olivier Bonnot, Ramon Mocellin, Dennis Velakoulis

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

A number of metabolic disorders that affect the central nervous system can present in childhood, adolescence or adulthood as a phenocopy of a major psychiatric syndrome such as psychosis, depression, anxiety or mania. An understanding and awareness of secondary syndromes in metabolic disorders is of great importance as it can lead to the early diagnosis of such disorders. Many of these metabolic disorders are progressive and may have illness-modifying treatments available. Earlier diagnosis may prevent or delay damage to the central nervous system and allow for the institution of appropriate treatment and family and genetic counselling. Metabolic disorders appear to result in neuropsychiatric illness either through disruption of late neurodevelopmental processes (metachromatic leukodystrophy, adrenoleukodystrophy, GM2 gangliosidosis, Niemann-Pick type C, cerebrotendinous xanthomatosis, neuronal ceroid lipofuscinosis, and alpha mannosidosis) or via chronic or acute disruption of excitatory/inhibitory or monoaminergic neurotransmitter systems (acute intermittent porphyria, maple syrup urine disease, urea cycle disorders, phenylketonuria and disorders of homocysteine metabolism). In this manuscript we review the evidence for neuropsychiatric illness in major metabolic disorders and discuss the possible models for how these disorders result in psychiatric symptoms. Treatment considerations are discussed, including treatment resistance, the increased propensity for side-effects and the possibility of some treatments worsening the underlying disorder.

Abbott MH et al (1987) Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet 26:959–969CrossRefPubMed

Alonso-Navarro H et al (2005) Kluver-Bucy syndrome as the initial symptom of adult-type ceroid lipofuscinosis (Kufs’ disease). Rev Neurol 40:93–98PubMed

Anderson PJ, Leuzzi V (2010) White matter pathology in phenylketonuria. Mol Genet Metab 99(Suppl 1):S3–S9CrossRefPubMed

Ara J et al (1999) Neurological impairment in alpha mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15:369–371CrossRefPubMed

Argov Z, Navon R (1984) Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann Neurol 16:14–20CrossRefPubMed

Arinami T et al (1997) Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74:526–528CrossRefPubMed

Augustine A et al (1993) Adult neuronal ceroid lipofuscinosis presenting with psychiatric symptoms: a case report. Int J Psychiatry Med 23:315–322CrossRefPubMed

Backman M et al (2005) Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intell Dis Res 49:25–32CrossRef

Bartzokis G et al (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60:393–398CrossRefPubMed

Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58:55–63CrossRefPubMed

Belanger-Quintana A et al (2003) Hyperammonaemia as a cause of psychosis in an adolescent. Eur J Pediatr 162:773–775CrossRefPubMed

Benes FM et al (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 51:477–484CrossRefPubMed

Berginer V et al (1988) Psychiatric disorders in patients with cerebrotendinous xanthomatosus. Am J Psychiatry 145:354–357PubMed

Berginer V et al (1994) Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study. Neurol Sci 122:102–108CrossRef

Berkovic S et al (1988) Kuf’s disease: a critical re-appraisal. Brain 111:27–62CrossRefPubMed

Bick U et al (1991) Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr 150:185–189CrossRefPubMed

Birnbaum T et al (2008) Methylenetetrahydrofolate reductase deficiency (homocystinuria type II) as a rare cause of rapidly progressive tetraspasticity and psychosis in a previously healthy adult. J Neurol 255:1845–1846CrossRefPubMed

Black DN et al (2003) Metachromatic leukodystrophy: a model for the study of psychosis. J Neuropsychiatry Clin Neurosci 15:289–293CrossRefPubMed

Bogdanovic MD et al (2000) Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69:813–815CrossRefPubMed

Bouwman MG et al (2011) Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of life. Mol Genet Metab 104:308–313CrossRefPubMed

Braak H, Braak E (1993) Pathoarchitectonic pattern of iso- and allocortical lesions in juvenile and adult neuronal ceroid lipofuscinoses. J Inherit Metab Dis 16:259–262CrossRefPubMed

Bracken P, Coll P (1985) Homocystinuria and schizophrenia. Literature review and case report. J Nerv Ment Dis 173:51–55CrossRefPubMed

Braissant O et al (2002) Ammonium-induced impairment of axonal growth is prevented through glial creatine. J Neurosci 22:9810–9820PubMed

Breen L et al (1981) Juvenile Niemann-Pick disease with vertical supranuclear opthalmoplegia. Arch Neurol 38:388–390CrossRefPubMed

Brenhouse HC, Andersen SL (2011) Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci Biobehav Rev 35:1687–1703CrossRefPubMed

Brumm VL et al (2010) Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 99(Suppl 1):S59–S63CrossRefPubMed

Burton BK, Leviton L (2010) Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU). Mol Genet Metab 101:146–148CrossRefPubMed

Byun K et al (2011) Alteration of the CNS pathway to the hippocampus in a mouse model of Niemann-Pick, type C disease. J Chem Neuroanat 42:39–44CrossRefPubMed

Cagnin A et al (2011) Gamma-Hydroxybutyric acid-induced psychosis and seizures. Epilepsy Behav 21:203–205CrossRefPubMed

Callagy C et al (2000) Adult neuronal ceroid lipofuscinosis (Kufs’ disease) in two siblings of an Irish family. Clin Neuropathol 19:109–118PubMed

Campo J et al (1998) Psychosis as a presentation of physical disease in adolescence: a case of Niemann-Pick disease typc C. Dev Med Child Neurol 40:126–129CrossRefPubMed

Carecchio M et al (2011) Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord 26:1324–1328CrossRefPubMed

Castellote A et al (1995) MR in adrenoleukodystrophy: atypical presentation as bilateral frontal demyelination. AJNR Am J Neuroradiol 16:814–815PubMed

Cazzorla C et al (2012) Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases. Mol Genet Metab 106:25–30CrossRefPubMed

Chang CC et al (2010) Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations. BMC Neurol 10:59CrossRefPubMed

Charles N et al (1990) Dementia and psychiatric disorders in Kufs disease. Rev Neurol (Paris) 146:752–756

Chen JJ et al (2012a) Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 34:1487–1504CrossRefPubMed

Chen Q et al (2012b) Fluoxetine-responsive depression in a Chinese cerebrotendinous xanthomatosis. Gen Hosp Psychiatry 34(578):e1–e4

Chopra A et al (2012) Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry 34:290–298CrossRefPubMed

Christ SE et al (2010a) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99(Suppl 1):S22–S32CrossRefPubMed

Christ SE et al (2010b) Disruption of prefrontal function and connectivity in individuals with phenylketonuria. Mol Genet Metab 99(Suppl 1):S33–S40CrossRefPubMed

Cleary MA et al (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87–90CrossRefPubMed

Cleary MA et al (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255CrossRefPubMed

Cole AL et al (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951CrossRefPubMed

Constantinidis J et al (1992) The adult and a new late adult forms of neuronal ceroid lipofuscinosis. Acta Neuropathol 83:461–468CrossRefPubMed

Crimlisk HL (1997) The little imitator–porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 62:319–328CrossRefPubMed

Dalmau J et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74CrossRefPubMed

Davey CG et al (2008) The emergence of depression in adolescence: development of the prefrontal cortex and the representation of reward. Neurosci Biobehav Rev 32:1–19CrossRefPubMed

de Groot MJ et al (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–S89CrossRefPubMed

De Stefano N et al (2001) Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 124:121–131CrossRefPubMed

Dietemann J et al (1990) MR findings in mannosidosis. Neuroradiology 33:485–487CrossRef

Di Forti M et al (2007) Risk factors for schizophrenia–all roads lead to dopamine. Eur Neuropsychopharmacol 17(Suppl 2):S101–S107CrossRefPubMed

D’Incerti L (2000) MRI in neuronal ceroid lipofuscinosis. Neurol Sci 21:S71–S73CrossRefPubMed

Dotti M et al (1991) Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing. Dev Neurosci 13:371–376CrossRefPubMed

Dotti M et al (1994) Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. AJNR 15:1721–1726PubMed

Dyer C (1999) Pathophysiology of phenylketonuria. Ment Retard Dev Disabil Res Rev 5:104–112CrossRef

Eather G et al (2006) Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old. J Clin Neurosci 13:702–706CrossRefPubMed

Edwin D et al (1990) Cognitive impairment in adult-onset adrenoleukodystrophy. Mol Chem Neuropathol 12:167–176

Elleder M et al (1985) Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol 66:325–366CrossRefPubMed

Ellencweig N et al (2006) Acute intermittent porphyria: psychosis as the only clinical manifestation. Isr J Psychiatry Relat Sci 43:52–56PubMed

Elstein D et al (2008) Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study. J Inherit Metab Dis 31:518–523CrossRefPubMed

Engelbrecht V et al (1997) MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency. AJNR Am J Neuroradiol 18:536–539PubMed

Enns GM et al (2005) Postpartum “psychosis” in mild argininosuccinate synthetase deficiency. Obstet Gynecol 105:1244–1246CrossRefPubMed

Eschweiler G et al (1997) Postoperative psychosis in homocystinuria. Eur Psychiatry 12:98–101CrossRefPubMed

Fassier T et al (2011) Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry 168:576–580CrossRefPubMed

Federico A et al (1991) The clinical aspects of adult hexosaminidase deficiencies. Dev Neurosci 13:280–287CrossRefPubMed

Fernandez SP, Gaspar P (2012) Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 62:144–154CrossRefPubMed

Fink J et al (1989) The clinical spectrum of Niemann-Pick disease type C. Neurology 39:104–01049

Fluharty AL (1990) The relationship of the metachromatic leukodystrophies to neuropsychiatric disorders. Mol Chem Neuropathol 13:81–94.CrossRefPubMed

Frey L et al (2005) The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. Arch Neurol 62:989–994CrossRefPubMed

Friston KJ, Frith CD (1995) Schizophrenia: a disconnection syndrome? Clin Neurosci 3:89–97PubMed

Funchal C et al (2005) Morphological alterations and cell death provoked by the branched-chain alpha-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex. Cell Mol Neurobiol 25:851–867CrossRefPubMed

Fuster JM (2002) Frontal lobe and cognitive development. J Neurocytol 31:373–385CrossRefPubMed

Gairing S et al (2011) Fabry’s disease and psychosis: causality or coincidence? Psychopathology 44:201–204CrossRefPubMed

Gaspari R et al (2003) Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann Emerg Med 41:104–109CrossRefPubMed

Gentile JK et al (2010) Psychosocial aspects of PKU: hidden disabilities—a review. Mol Genet Metab 99(Suppl 1):S64–S67CrossRefPubMed

German D et al (2002) Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 109:437–450CrossRefPubMed

Goebel HH, Braak H (1989) Adult neuronal ceroid-lipofuscinosis. Clin Neuropathol 8:109–119PubMed

Gogtay N et al (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101:8174–8179CrossRefPubMed

Gonzalez MJ et al (2011) Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Mol Genet Metab 104(Suppl):S73–S79CrossRefPubMed

Gorman JM et al (2002) New developments in the neurobiological basis of anxiety disorders. Psychopharmacol Bull 36(Suppl 2):49–67PubMed

Gospe SJ, Jankovic J (1986) Drug-induced dystonia in neuronal ceroid lipofuscinosis. Pediatr Neurol 2:236–237CrossRefPubMed

Grau A et al (1997) Adult Niemann-Pick disease type C mimicking features of multiple sclerosis. J Neurol Neurosurg Psychiatry 63:522–525CrossRef

Gravel R et al (1995) The GM2 gangliosidoses. In: Scriber C et al (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2839–2879

Gravel R et al (2001) The GM2 gangliosidoses. In: Scriver C et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3827–3865

Grewal RP (1993) Psychiatric disorders in patients with Fabry’s disease. Int J Psychiatry Med 23:307–312CrossRefPubMed

Gropman A (2010) Brain imaging in urea cycle disorders. Mol Genet Metab 100(Suppl 1):S20–S30CrossRefPubMed

Gropman AL et al (2007) Neurological implications of urea cycle disorders. J Inherit Metab Dis 30:865–879CrossRefPubMed

Guerrera S et al (2010) Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 81:1189–1193CrossRefPubMed

Gurden H et al (1999) Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. Neuroscience 94:1019–1027CrossRefPubMed

Gutschalk A et al (2004) Adult alpha mannosidosis: clinical progression in the absence of demyelination. Neurology 63:1744–1746CrossRefPubMed

Guyant-Marechal L et al (2005) Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet 139:114–117CrossRef

Hamner MB (1998) Recurrent psychotic depression associated with GM2 gangliosidosis. Psychosomatics 39:446–448CrossRefPubMed

Harzer K et al (1978) Neurovisceral lipidosis compatible with Niemann-Pick disease type C: morphological and biochemical studies of a late infantile case and enzyme and lipid assays in a prenatal case of the same family. Acta Neuropathol 43:97–104CrossRefPubMed

Hermle L et al (1997) Metachromatic leukodystrophy simulating schizophrenia-like psychosis. Nervenarzt 68:754–758CrossRefPubMed

Hilliges C et al (1993) Intellectual performance of children with maple syrup urine disease. Eur J Pediatr 152:144–147CrossRefPubMed

Hinkebein J, Callahan C (1997) The neuropsychology of Kuf’s disease: a case of atypical early onset dementia. Arch Clin Neuropsychol 12:81–89PubMed

Ho NC et al (2003) Famous people and genetic disorders: from monarchs to geniuses—a portrait of their genetic illnesses. Am J Med Genet A 118A:187–196CrossRefPubMed

Hoeksma M et al (2009) Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis. Mol Genet Metab 96:177–182CrossRefPubMed

Hoffmann B et al (2006) Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. Pediatr Res 59:17–20CrossRefPubMed

Holroyd S, Seward RL (1999) Psychotropic drugs in acute intermittent porphyria. Clin Pharmacol Ther 66:323–325CrossRefPubMed

Holtzman NA et al (1986) Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med 314:593–598CrossRefPubMed

Hughes JR (2009) Alcohol withdrawal seizures. Epilepsy Behav 15:92–97CrossRefPubMed

Hughes EG et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866–5875CrossRefPubMed

Hurowitz G et al (1993) Neuropsychiatric aspects of adult-onset Tay Sachs disease: two case reports with several new findings. J Neuropsychiatry Clin Neurosci 5:30–36PubMed

Hyde TM et al (1992) Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol 49:401–406CrossRefPubMed

Inoue K, Lupski JR (2003) Genetics and genomics of behavioral and psychiatric disorders. Curr Opin Genet Dev 13:303–309CrossRefPubMed

Inoue S et al (2012) A case of adult-onset adrenoleukodystrophy with frontal lobe dysfunction: a novel point mutation in the ABCD1 gene. Intern Med 51:1403–1406CrossRefPubMed

Insel TR et al (1990) The ontogeny of excitatory amino acid receptors in rat forebrain–I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience 35:31–43CrossRefPubMed

Jan W et al (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393–399CrossRefPubMed

Janzen D, Nguyen M (2010) Beyond executive function: non-executive cognitive abilities in individuals with PKU. Mol Genet Metab 99(Suppl 1):S47–S51CrossRefPubMed

Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69–108CrossRefPubMed

Joseph B, Dyer CA (2003) Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J Neurochem 86:615–626CrossRefPubMed

Josephs K et al (2003) Adult-onset Niemann-Pick disease type C presenting with psychosis. JNNP 74:528–529

Jouvet P et al (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919–1932CrossRefPubMed

Kalsbeek A et al (1988) Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269:58–72CrossRefPubMed

Kamei A et al (1992) Abnormal dendritic development in maple syrup urine disease. Pediatr Neurol 8:145–147CrossRefPubMed

Kaplan P et al (1991) Intellectual outcome in children with maple syrup urine disease. J Pediatr 119:46–50CrossRefPubMed

Karten B et al (2003) Trafficking of cholesterol from cell bodies to distal axons in Niemann Pick C1-deficiant neurons. J Biol Chem 278:4168–4175CrossRefPubMed

Kessler RC et al (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602CrossRefPubMed

Kinney HC et al (1994) Myelination in the developing human brain: biochemical correlates. Neurochem Res 19:983–996CrossRefPubMed

Koch R et al (2002) Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 25:333–346CrossRefPubMed

Korein J et al (1994) Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci 79:21–45PubMed

Kornfeld M (2008) Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase A deficiency. Clin Neuropathol 27:302–308PubMed

Kozian R et al (2007) Frontotemporal dementia in metachromatic leukodystrophy. Fortschr Neurol Psychiatr 75:549–551CrossRefPubMed

Kruszewski SP et al (2009) Gabapentin-induced delirium and dependence. J Psychiatr Pract 15:314–319CrossRefPubMed

Kumar B (2012) Acute intermittent porphyria presenting solely with psychosis: a case report and discussion. Psychosomatics 53:494–498CrossRefPubMed

Kunugi H et al (1998) C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3:435–437CrossRefPubMed

Laney DA et al (2010) Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 2010 Jan 20. [Epub ahead of print]

Lee Y et al (2002) Cerebrotendinous xanthomatosis with psychiatric disorder: report of three siblings and literature review. Chang Gung Med J 25:334–340PubMed

Legras A et al (2002) Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. Crit Care Med 30:241–244CrossRefPubMed

le Roux C et al (2006) Neuropsychometric outcome predictors for adults with maple syrup urine disease. J Inherit Metab Dis 29:201–202CrossRefPubMed

Lewandowska E et al (2009) Kufs’ disease: diagnostic difficulties in the examination of extracerebral biopsies. Folia Neuropathol 47:259–267PubMed

Li SC, Stewart PM (1999) Homocystinuria and psychiatric disorder: a case report. Pathology 31:221–224CrossRefPubMed

Lidow MS, Rakic P (1992) Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2:401–416CrossRefPubMed

Lien J et al (2007) Fatal initial adult-onset presentation of urea cycle defect. Arch Neurol 64:1777–1779CrossRefPubMed

Lipowski ZJ (1984) Organic brain syndromes: new classification, concepts and prospects. Can J Psychiatry 29:198–204PubMed

Lossos A et al (1997) Adult-onset Niemann-Pick type C disease: clinical, biochemical and genetic study. Arch Neurol 54:1536–1541CrossRefPubMed

Low M et al (2007) Neurology of Fabry disease. Intern Med J 37:436–447CrossRefPubMed

Luda E, Barisone MG (2001) Adult-onset adrenoleukodystrophy: a clinical and neuropsychological study. Neurol Sci 22:21–25CrossRefPubMed

MacDonald JT et al (1984) Adrenoleukodystrophy: early frontal lobe involvement on computed tomography. J Comput Assist Tomogr 8:128–130CrossRefPubMed

MacQueen G et al (1998) Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 10:10–19PubMed

Malm D et al (2005) Psychiatric symptoms in mannosidosis. J Intell Dis Res 49:865–871CrossRef

Manara R et al (2009) Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria. Neuroradiology 51:803–812CrossRefPubMed

Manor I et al (1997) Neuroleptic malignant syndrome with gangliosidosis type II. Biol Psychiatry 41:1222–1224CrossRefPubMed

March P et al (1997) GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol 94:164–172CrossRefPubMed

McEwin R et al (1972) A survey of porphyria among psychiatric patients. Med J Aust 2:303–306PubMed

McGlashan TH, Hoffman RE (2000) Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57:637–648CrossRefPubMed

Mehta AB (2009) Anderson-Fabry disease: developments in diagnosis and treatment. Int J Clin Pharmacol Ther 47(Suppl 1):S66–S74PubMed

Mehta A et al (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet 46:548–552CrossRefPubMed

Meyer UA et al (1998) Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 18:43–52CrossRefPubMed

Michot JM et al (2008) Psychosis, paraplegia and coma revealing methylenetetrahydrofolate reductase deficiency in a 56-year-old woman. J Neurol Neurosurg Psychiatry 79:963–964CrossRefPubMed

Miller HL et al (1996) Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 53:117–128CrossRefPubMed

Moghadasian M et al (2002) Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol 59:527–529CrossRefPubMed

Muller WE, Snyder SH (1977) Delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol 2:340–342CrossRefPubMed

Muntjewerff JW et al (2006) Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 11:143–149CrossRefPubMed

Muntjewerff JW et al (2008) Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. Eur Neuropsychopharmacol 18:99–106CrossRefPubMed

Nassogne MC et al (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407–414CrossRefPubMed

Navon R et al (1986) Hexosaminidase deficiency in adults. Am J Med Genet 24:179–196CrossRefPubMed

Neudorfer O et al (2005) Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlation in 21 affected patients. Genet Med 7:119–123CrossRefPubMed

Nijssen PC et al (2009) Electroencephalography in autosomal dominant adult neuronal ceroid lipofuscinosis. Clin Neurophysiol 120:1782–1786CrossRefPubMed

Norenberg MD et al (2005) Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 20:303–318CrossRefPubMed

Oates C et al (1986) Movement disorders associated with chronic GM2 gangliosidosis: case report and review of the literature. Eur Neurol 25:154–159CrossRefPubMed

Oldham MS et al (2010) Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts. Pediatr Neurol 42:49–52CrossRefPubMed

Ong W et al (2001) Neurodegeneration in Niemann-Pick type C disease mice. Exp Brain Res 141:218–231CrossRefPubMed

Packman W et al (2012) Young adults with MSUD and their transition to adulthood: psychosocial issues. J Genet Couns 21:692–703CrossRefPubMed

Palmeri S et al (1994) Hypoplasia of the corpus callosum in Niemann-Pick type C disease. Neuroradiology 36:20–22CrossRefPubMed

Panlaqui OM et al (2008) Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency. Intensive Care Med 34:1922–1924CrossRefPubMed

Patel PJ et al (1995) Adrenoleukodystrophy: CT and MRI findings. Pediatr Radiol 25:256–258CrossRefPubMed

Paus T et al (1999) Structural maturation of neural pathways in children and adolescents: in vivo study. Science 283:1908–1911CrossRefPubMed

Peerbooms OL et al (2011) Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 25:1530–1543CrossRefPubMed

Peterson DE (2003) Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency. Obstet Gynecol 102:1212–1215CrossRefPubMed

Pettersson-Yeo W et al (2011) Dysconnectivity in schizophrenia: where are we now? Neurosci Biobehav Rev 35:1110–1124CrossRefPubMed

Pierach CA, Edwards PS (1978) Neurotoxicity of delta-aminolevulinic acid and porphobilinogen. Exp Neurol 62:810–814CrossRefPubMed

Poll-The BT, Gartner J (2012) Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 1822:1421–1429CrossRefPubMed

Prensky AL, Moser HW (1966) Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem 13:863–874CrossRefPubMed

Pressey SN et al (2012) Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol Dis 45:1086–1100CrossRefPubMed

Puglisi-Allegra S et al (2000) Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria. Neuroreport 11:1361–1364CrossRefPubMed

Purpura D, Suzuki K (1976) Distortion of neuronal geometry and formation of aberrant synopsis in neuronal storage disease. Brain Res 116:1–21CrossRefPubMed

Rauschka H et al (2006) Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67:859–863CrossRefPubMed

Regenold WT et al (2007) Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 151:179–188CrossRefPubMed

Regland B et al (1997) Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J Neural Transm 104:931–941CrossRefPubMed

Reider-Grosswasser I, Bornstein N (1987) CT and MRI in late-onset metachromatic leukodystrophy. Acta Neurol Scand 75:64–69CrossRefPubMed

Reif A et al (2003) Neuroleptic malignant syndrome in Kuf’s disease. J Neurol Neurosurg Psychiatry 74:385–387CrossRefPubMed

Reif A et al (2005) Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 29:1162–1168CrossRefPubMed

Reisin RC et al (2011) Brain MRI findings in patients with Fabry disease. J Neurol Sci 305:41–44CrossRefPubMed

Renshaw P et al (1992) Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. Ann Neurol 31:342–344CrossRefPubMed

Ris MD et al (1997) Adult psychosocial outcome in early-treated phenylketonuria. J Inherit Metab Dis 20:499–508CrossRefPubMed

Robinson MB et al (1995) Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Brain Res Dev Brain Res 90:35–44CrossRefPubMed

Rose FC (2006) Van Gogh’s madness. Int Rev Neurobiol 74:253–269CrossRefPubMed

Rosebush P et al (1995) Late-onset Tay Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry 56:347–353PubMed

Rosebush PI et al (1999) The neuropsychiatry of adult-onset adrenoleukodystrophy. J Neuropsychiatry Clin Neurosci 11:315–327PubMed

Rosebush P et al (2010) Psychosis associated with leukodystrophies. In: Sachdev P, Keshavan M (eds) Secondary schizophrenia. Cambridge University Press, pp. 241–256

Ruhe HG et al (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12:331–359CrossRefPubMed

Ryan MM et al (2002) Homocystinuria presenting as psychosis in an adolescent. J Child Neurol 17:859–860CrossRefPubMed

Sadek J et al (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201CrossRefPubMed

Sandu S et al (2009) Niemann-Pick disease type C1 presenting with psychosis in an adolescent male. Eur Child Adolesc Psychiatry 18:583–585CrossRefPubMed

Santiago RM et al (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson’s disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry 34:1104–1114CrossRefPubMed

Santosh PJ, Malhotra S (1994) Varied psychiatric manifestations of acute intermittent porphyria. Biol Psychiatry 36:744–747CrossRefPubMed

Saudubray JM (2009) Neurometabolic disorders. J Inherit Metab Dis 32:595–596CrossRefPubMed

Sayit E et al (2002) Comparison of brain perfusion SPECT and MRI findings in children with neuronal ceroid-lipofuscinosis and in their families. Ann Nucl Med 16:201–206CrossRefPubMed

Scarabino T et al (2009) Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol Med 114:461–474CrossRefPubMed

Schermuly I et al (2011) Neuropsychiatric symptoms and brain structural alterations in Fabry disease. Eur J Neurol Off J Eur Fed Neurol Soc 18:347–353

Schiffman R (1996) Niemann-Pick disease type C: from bench to bedside. JAMA 276:561–564CrossRef

Schiffmann R (2009) Fabry disease. Pharmacol Ther 122:65–77CrossRefPubMed

Schonberger S et al (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75CrossRefPubMed

Schreiber SS, Baudry M (1995) Selective neuronal vulnerability in the hippocampus—a role for gene expression? Trends Neurosci 18:446–451CrossRefPubMed

Schreiner R et al (2000) Kuf’s disease: a rare cause of early-onset dementia. Nervenarzt 71:411–415CrossRefPubMed

Schurr A et al (1993) The neurotoxicity of sulfur-containing amino acids in energy-deprived rat hippocampal slices. Brain Res 601:317–320CrossRefPubMed

Scriver C, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver C et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1667–1724

Sedel F et al (2007) Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 30:631–641CrossRefPubMed

Segal P et al (2010) Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study. J Inherit Metab Dis 33:429–436CrossRefPubMed

Seidl U et al (2004) Unusual course of alpha mannosidosis with symptoms of paranoid-hallucinatory psychosis. Nervenarzt 76:335–338CrossRef

Selema G et al (1997) Sulphur-containing amino acids modulate noradrenaline release from hippocampal slices. J Neurochem 68:1534–1541CrossRefPubMed

Shapiro S (1983) Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis. J Nerv Ment Dis 171:568–571CrossRefPubMed

Shapiro EG et al (1994) Characteristics of the dementia in late-onset metachromatic leukodystrophy. Neurology 44:662–665CrossRefPubMed

Shaw, P. Gogtay, N. Rapoport, J. Childhood psychiatric disorders as anomalies in neurodevelopmental trajectories. Hum Brain Mapp 31:917-925, 2010

Shen YC et al (2007) Psychosis in a patient with Fabry’s disease and treatment with aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 31:779–780CrossRefPubMed

Shulman L et al (1995a) Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type C. Neurology 45:1739–1743CrossRefPubMed

Shulman L et al (1995b) Case 1, 1995: psychosis, dementia, chorea, ataxia and supranuclear gaze dysfunction. Mov Disord 10:257–262CrossRefPubMed

Simon E et al (2007) Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis 30:264CrossRefPubMed

Simon E et al (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 6:25CrossRefPubMed

Smith I et al (1988) Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr 112:403–408CrossRefPubMed

Soffer D et al (1995) The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol 90:213–220CrossRefPubMed

Sowell ER et al (2002) Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev Med Child Neurol 44:4–16CrossRefPubMed

Sowell ER et al (2003) Mapping cortical change across the human life span. Nat Neurosci 6:309–315CrossRefPubMed

Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417–463CrossRefPubMed

Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341CrossRefPubMed

Strauss KA et al (2010) Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab 99:333–345CrossRefPubMed

Streifler J et al (1989) Psychiatric features of adult GM2 gangliosidosis. Br J Psychiatry 155:410–413PubMed

Streifler J et al (1993) Brain imaging in late-onset GM2 gangliosidosis. Neurology 43:2055–2058CrossRefPubMed

Su CS et al (2010) Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord Off J Mov Disord Soc 25:452–458CrossRef

Sullivan D et al (2005) Bipolar disorder and Niemann-Pick disease type C. Am J Psychiatry 165:1021–1022CrossRef

Sun H, Wolfe J (2001) Recent progress in lysosomal alpha mannosidase and its deficiency. Exp Mol Med 33:1–7CrossRefPubMed

Sung J et al (1977) Mannosidosis: pathology of the nervous system. J Neuropathol Exp Neurol 36:807–820CrossRefPubMed

Suzuki K (1991) Neuropathology of late onset gangliosidoses. A review. Dev Neurosci 13:205–210CrossRefPubMed

Tau GZ, Peterson BS (2010) Normal development of brain circuits. Neuropsychopharmacology 35:147–168CrossRefPubMed

Tedeschi G et al (1998) Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. J Neurol Neurosurg Psychiatry 65:72–79CrossRefPubMed

Thurlow VR et al (2010) Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency. Ann Clin Biochem 47:279–281CrossRefPubMed

Tishler PV et al (1985) High prevalence of intermittent acute porphyria in a psychiatric patient population. Am J Psychiatry 142:1430–1436PubMed

Tobo M et al (1984) Familial occurrence of adult-type neuronal ceroid lipofuscinosis. Arch Neurol 41:1091–1094CrossRefPubMed

Tonini MC et al (2011) Headache and neuropsychic disorders in the puerperium: a case report with suspected deficiency of urea cycle enzymes. Neurol Sci 32(Suppl 1):S157–S159CrossRefPubMed

Turpin J et al (1991) Type C Niemann-Pick disease: supranuclear opthalmoplegia assocated with deficient biosynthesis of cholesterol esters. Rev Neurol (Paris) 147:28–34

Vanier M (1999) Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 24:481–489CrossRefPubMed

van Spronsen FJ et al (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51CrossRefPubMed

Vatanavicharn N et al (2008) Reversible leukoencephalopathy with acute neurological deterioration and permanent residua in classical homocystinuria: a case report. J Inherit Metab Dis doi: 10.1007/s10545-007-0791-8

Vercammen L et al (2003) Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy. J Inherit Metab Dis 26:611–612CrossRefPubMed

Vite C et al (2001) Histopathology, electrodiagnostic testing and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha mannosidosis. J Neuropathol Exp Neurol 60:817–828PubMed

Waisbren SE, Zaff J (1994) Personality disorder in young women with treated phenylketonuria. J Inherit Metab Dis 17:584–592CrossRefPubMed

Waldman A (1992) Sometimes when you hear hoofbeats… two cases of inherited metabolic diseases with initial presentation of psychiatric symptoms. J Neuropsychiatry Clin Neurosci 4:113–114PubMed

Walkley S (1988) Pathobiology of neuronal storage disease. Int Rev Neurobiol 29:191–244CrossRefPubMed

Walkley SU et al (1990) Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. Brain Res Dev Brain Res 51:167–178CrossRefPubMed

Wallon D et al (2010) Clinical imaging and neuropathological correlations in an unusual case of cerebrotendinous xanthomatosis. Clin Neuropathol 29:361–364PubMed

Walsh KS, Scott MN (2010) Neurocognitive profile in a case of maple syrup urine disease. Clin Neuropsychol 24:689–700CrossRefPubMed

Walter JH et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57CrossRefPubMed

Walterfang M et al (2005) Diseases of white matter and schizophrenia-like psychosis. Aust N Z J Psychiatry 39:746–756CrossRefPubMed

Walterfang M et al (2006a) The neuropsychiatry of adult-onset Niemann-Pick type C disease. J Neuropsychiatry Clin Neurosci 18:158–170CrossRefPubMed

Walterfang M et al (2006b) The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 18:158–170CrossRefPubMed

Walterfang M et al (2006c) Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci Biobehav Rev 30:918–948CrossRefPubMed

Walterfang MA et al (2007) The neuropsychiatry of adrenomyeloneuropathy. CNS Spectrums 12:696–701PubMed

Walterfang M et al (2009a) Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. J Inherit Metab Dis doi: 10.1007/s10545-009-1173-1

Walterfang M et al (2009b) The neuropsychiatry of neurometabolic and neuroendocrine disorders. In: Sadock B et al (eds) Kaplan and Sadock’s comprehensive textbook of psychiatry. Lippincott Williams and Wilkins, Philadelphia, pp 592–618

Walterfang M et al (2010) White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology 75:49–56CrossRefPubMed

Walterfang M et al (2011) Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables. AJNR Am J Neuroradiol 32:1340–1346CrossRefPubMed

Walterfang M et al (2012a) Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol Off J Eur Fed Neurol Soc 19:462–467

Walterfang M et al (2012b) Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study. Am J Neuroradiol 2012 Dec 13. [Epub ahead of print]

Weglage J et al (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria–result of impaired frontal lobe functions? Eur J Pediatr 155:200–204CrossRefPubMed

White DA et al (2010) Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosum. Mol Genet Metab 99(Suppl 1):S41–S46CrossRefPubMed

Wisniewski K et al (2001) Neruonal ceoid lipofuscinoses: classification and diagnosis. Adv Genet 45:1–34CrossRefPubMed

Yudkoff M et al (1996) Astrocyte leucine metabolism: significance of branched-chain amino acid transamination. J Neurochem 66:378–385CrossRefPubMed

Zaroff C et al (2004) Neuropsychological assessment of patients with late-onset GM2 gangliosidosis. Neurology 62:2283–2286CrossRefPubMed

Zecevic N, Rakic P (2001) Development of layer I neurons in the primate cerebral cortex. J Neurosci 21:5607–5619PubMed

Zervas M et al (2001) Neurons in Niemann-Pick type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60:49–64PubMed

Zini A et al (2008) Early-onset dementia with prolonged occipital seizures: an atypical case of Kufs disease. Neurology 71:1709–1712CrossRefPubMed

Zinnanti WJ et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132:903–918CrossRefPubMed

Titel: The neuropsychiatry of inborn errors of metabolism
verfasst von: Mark Walterfang
Olivier Bonnot
Ramon Mocellin
Dennis Velakoulis
Publikationsdatum: 01.07.2013
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 4/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-013-9618-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The neuropsychiatry of inborn errors of metabolism

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Impact of new screening technologies: should we screen and does phenotype influence this decision?

Ammonia toxicity to the brain

Erratum to: Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan

Gastrointestinal and hepatic manifestations of mitochondrial disorders

Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation

Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin